WoodwardA, WestonP, CassonIF, GillGV. Nocturnal hypoglycaemia in type 1 diabetes—frequency and predictive factors. QJM, 2009; 102:603–607.
3.
WentholtIM, MaranA, MasurelN, HeineRJ, HoekstraJB, DeVriesJH. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med, 2007; 24:527–532.
4.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care, 2010; 33:1004–1008.
5.
DavisEA, KeatingB, ByrneGC, RussellM, JonesTW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care, 1997; 20:22–25.
6.
TanenbergRJ, NewtonCA, DrakeAJ. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract, 2010; 16:244–248.
7.
MurphyNP, Ford-AdamsME, OngKK, HarrisND, KeaneSM, DaviesC, IrelandRH, MacDonaldIA, KnightEJ, EdgeJA, HellerSR, DungerDB. Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia, 2004; 47:1940–1947.
8.
KossoffEH, IchordRN, BerginAM. Recurrent hypoglycemic hemiparesis and aphasia in an adolescent patient. Pediatr Neurol, 2001; 24:385–386.
9.
KingP, KongMF, ParkinH, MacdonaldIA, TattersallRB. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care, 2008; 21:341–345.
10.
Jauch-CharaK, HallschmidM, GaisS, SchmidSM, OltmannsKM, ColmorgenC, BornJ, SchultesB. Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans. Diabetes Care, 2007; 30:2040–2045.
11.
DesouzaCV, BolliGB, FonsecaV. Diabetes, hypoglycaemia and vascular complications. Diabetes Care, 2010; 33:1389–1394.
12.
FanelliCG, ParamoreDS, HersheyT, TerkampC, OvalleF, CraftS, CryerPE. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes, 1998; 47:1920–1927.
13.
JonesTW, PorterP, SherwinRS, DavisEA, O’LearyP, FrazerF, ByrneG, StickS, TamborlaneWV. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med, 1998; 338:1657–1662.
14.
BuckinghamB, BlockJ, BurdickJ, KalajianA, KollmanC, ChoyM, WilsonDM, ChaseP. Diabetes Research in Children Network: Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther, 2005; 7:440–447.
15.
LyTT, JonesTW, GriffithsA, DartJ, DavisEA, StickS, WilsonA. Hypoglycemia does not change the threshold for arousal from sleep in adolescents with type 1 diabetes. Diabetes Technol Ther, 2012; 14:101–104.
16.
RiddleMC, RosenstockJ, GerichJ. Insulin Glargine 4002 Study Investigators: The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care, 2003; 26:3080–3086.
17.
ChoudharyP, ShinJ, WangY, EvansML, HammondPJ, KerrD, ShawJA, PickupJC, AmielSA. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care, 2011; 34:2023–2025.
CITR Research Group. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR)Cell Transplant, 2009; 18:753–767.
